Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) CEO Brett Monia sold 21,072 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $78.49, for a total value of $1,653,941.28. Following the sale, the chief executive officer owned 245,571 shares in the company, valued […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Eric Swayze sold 10,602 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $79.18, for a total value of $839,466.36. Following the completion of the transaction, the executive vice president directly owned […]

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) CMO Carmen Bozic sold 1,020 shares of Vertex Pharmaceuticals stock in a transaction dated Thursday, June 18th. The shares were sold at an average price of $462.17, for a total transaction of $471,413.40. Following the transaction, the chief marketing officer directly owned 15,933 shares of the company’s […]

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) CEO Bobak Azamian sold 10,000 shares of the company’s stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of $61.55, for a total value of $615,500.00. Following the completion of the transaction, the chief executive officer owned 847,991 shares of […]

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) Director Derrell Porter sold 6,460 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $2.35, for a total transaction of $15,181.00. Following the completion of the sale, the director owned 48,300 shares in the company, […]